Skip to content

Omega-6 sparing effects of parenteral lipid emulsions—an updated systematic review and meta-analysis on clinical outcomes in critically ill patients

Critical Care
Q1
Jan 2022
Citations:33
Influential Citations:4
Systematic Reviews / Meta-Analyses
90
S2 IconPDF Icon

Enhanced Details

Methods
This systematic review and meta-analysis included 20 trials (n = 1366) in critically ill adults aged 18 years or older admitted to intensive care. It evaluated omega-6 fatty acid-sparing parenteral lipid emulsions versus standard lipid emulsions across mortality, length of stay, mechanical ventilation, and infectious complications, with subgroup analyses for fish oil-containing, Omegaven, stand-alone fish oil, and other lipid-emulsion strategies.
Intervention
Intravenous omega-6 fatty acid-sparing parenteral lipid emulsions were compared with standard lipid emulsions in critically ill adults receiving parenteral nutrition. The most studied regimens were fish oil-containing formulations, including Omegaven; reported fish oil dosing was 0.1-0.2 g/kg/day IV as part of PN.
Results
Overall, omega-6 fatty acid-sparing parenteral nutrition did not significantly reduce mortality versus control (RR 0.91, 95% CI 0.76 to 1.10; p = 0.34). The clearest benefit was with fish oil-containing PN, which reduced infectious complications (RR 0.65, 95% CI 0.44 to 0.95; p = 0.03) and was associated with shorter hospital stay (WMD -6.88, 95% CI -11.27 to -2.49; p = 0.002). ICU length of stay was not significantly reduced overall (WMD -1.94, 95% CI -4.41 to 0.52; p = 0.12), and duration of mechanical ventilation was also nonsignificant (WMD -0.87, 95% CI -1.82 to 0.07; p = 0.07). Fish oil-containing PN showed a mortality signal at 28 days (RR 0.74, 95% CI 0.54 to 1.01; p = 0.06), and Omegaven was associated with lower mortality (RR 0.68, 95% CI 0.48 to 0.95; p = 0.03).
Limitations
Findings were heterogeneous across lipid formulations, comparators, and outcomes, with substantial heterogeneity for ICU length of stay (I2 = 83%). Several analyses included relatively small numbers of studies or participants, many effects were borderline or nonsignificant, and detailed age, sex, geographic, and dietary information was not reported.

Abstract

Background Parenteral lipid emulsions in critical care are traditionally based on soybean oil (SO) and rich in pro-inflammatory omega-6 fatty acids (FAs). Parenteral nutrition (PN) strategies with the aim of reducing omega-6 FAs may potentially decre...